Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Delekang Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in the development and large-scale production of active pharmaceutical ingredients (APIs) and natural plant extracts. Founded in 1993 and headquartered in Zhejiang Province, the company has established itself as a premier global supplier of Gabapentin and Pregabalin, holding significant market shares in the United States, Europe, and Asia. Delekang operates state-of-the-art manufacturing facilities that comply with international quality standards, including US FDA, EU GMP, and PMDA certifications. In addition to its core synthetic API portfolio, the company is a major producer of standardized Ginkgo Biloba extracts used in various therapeutic and nutraceutical applications. As a vertically integrated manufacturer, Delekang provides comprehensive CDMO services and maintains a robust export business, supporting global pharmaceutical supply chains for neurological and psychiatric treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delekang.